Do Biotech Investors stick to their Home Market?

It is no surprise that most biotech investors are based in the US. But, do they invest exclusively in American companies? Read the report Would you like to be notified about new articles, reports and other valuable content published by Venture Valuation?

Read more

J.P. Morgan Healthcare Conference Round-up by Venture Valuation / Biotechgate

14 January 2019. Last week saw the annual J.P. Morgan Healthcare Conference held in San Francisco. Venture Valuation and Biotechgate was represented by CEO, Patrik Frei and Senior Business Development Executive Ray Carroll providing their insights into the industry announcements. It was again a busy week in San Francisco kicking off the Bio year 2019 … Continue reading J.P. Morgan Healthcare Conference Round-up by Venture Valuation / Biotechgate

Read more

The Mandarin translation of Site Selection Report for Life Sciences Companies in Europe 2018

Site Selection Report for Life Sciences Companies in Europe 2018 is now available in Mandarin and can be downloaded free by clicking at the link below: 生命科学企业在欧洲的选址(2018年版 The report, compiled by KPMG in association with Venture Valuation, explores the when, where and how of successful European expansion. The publication looks beyond site selection to include … Continue reading The Mandarin translation of Site Selection Report for Life Sciences Companies in Europe 2018

Read more

Site Selection Report for Life Sciences Companies in Europe 2018

The new Site Selection Report for Life Sciences Companies in Europe, compiled by KPMG in association with Venture Valuation, explores the when, where and how of successful European expansion. The publication looks beyond site selection to include key work streams involved in successfully commercializing pharmaceutical products in Europe. In the 2018 edition, we identify five … Continue reading Site Selection Report for Life Sciences Companies in Europe 2018

Read more

Life Sciences Clusters in Europe

What makes a European Life Science site attractive to foreign investors? Together with KPMG Switzerland Venture Valuation has published this second edition statistic and extensive numbers on the European Biotechnology, Medical Technology and Pharma environment. The data is based on Biotechgate, the global Life Sciences database. Site Selection for Life Sciences Companies in Europe 2015: … Continue reading Life Sciences Clusters in Europe

Read more

Preview. Site Selection for Life Sciences Companies: Cluster Report 2015

Venture Valuation presented a preview of its new report together with KPMG “Site Selection for Life Sciences Companies: Cluster Report 2015” in January at three locations including during JPMorgan in San Francisco, in Singapore and Taipei in February. The new report will be published in May 2015. For a copy of the key slides, please … Continue reading Preview. Site Selection for Life Sciences Companies: Cluster Report 2015

Read more